logo
Sign in

HTGMQ Stock Price, Chart, Stats & News

HTG Molecular Diagnostics, Inc.
Save

HTG Molecular Diagnostics, Inc. (HTGMQ) does not currently pay a dividend.

221
Market cap
Current P/E
Forward P/E

HTGMQ chart

1M
3M
1Y
5Y
Loading chart...

About

Health care
Sector
Medical - Diagnostics & Research
Industry

HTG Molecular Diagnostics, Inc. operates as a life sciences company, specializing in the realm of precision medicine. They furnish specialized instruments, consumable products, and software applications engineered to automate the processing of samples and characterize a variety of molecular targets. Among their portfolio of molecular profiling panels are offerings like the HTG Transcriptome Panel, HTG EdgeSeq precision immuno-oncology panel, HTG EdgeSeq miRNA whole-transcriptome assay, HTG EdgeSeq DLBCL cell of origin assay EU, HTG EdgeSeq Oncology Biomarker Panel, HTG immune response panel, and the HTG mouse mRNA tumor response panel.

Similar securities

Based on sector and market capitalization

Report issue